Hansen Medical, Inc. (NASDAQ:HNSN)

jeffrey42 (< 20) Submitted: 4/12/2007 11:24:25 AM : Start Price: $19.76 HNSN Score: -84.41

run by the same 2 guys who propelled Intuitive surgical from 20.00 to well over 100.00,with the Davinci systym. They now have a new surgery machine that they are pushing. I belive in them. Plus look at their track record(stock price) nothing but up,up,up!

anylawn (36.90) Submitted: 4/11/2007 4:49:35 PM : Start Price: $20.00 HNSN Score: -84.71

Great leadership in Frederic Moll formerly of ISRG.

FearlessFreep (< 20) Submitted: 4/3/2007 1:55:21 PM : Start Price: $18.56 HNSN Score: -83.66

Terrific management with a proven track record; Sensei product will greatly improve catheter-based interventional procedures at a lower cost to health care organizations than its chief competitor's product. Also, I believe the potential for this product in off-label applications is enormous.

spinbob7 (93.87) Submitted: 3/21/2007 8:52:00 PM : Start Price: $20.60 HNSN Score: -85.25

Brought to by the same people who helped found ISRG. Need I say more?

luisholl (46.20) Submitted: 3/21/2007 1:42:51 PM : Start Price: $20.84 HNSN Score: +86.88

This company hasn't received FDA clearance yet. I called their offices in California and they don't expect to receive clearance for at least 1 year. STXS numbers are great, and their international presence is still poor. STXS this year, HNSN next year, that's the way it'll work. Peace

NetscribeMedDevs (94.78) Submitted: 3/20/2007 8:11:06 AM : Start Price: $20.16 HNSN Score: +87.35

Hansen Medical, Inc. (Hansen) develops and manufactures a new generation of medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies.

The company’s Sensei™ Robotic Catheter System, is designed to allow physicians to instinctively navigate flexible catheters with greater stability and control in interventional procedures. Instinctive navigation refers to the ability of the Sensei system to enable physicians to direct the movements of Hansen Medical's Artisan™ Control Catheter, to a desired anatomical location in a way that is natural and inherently simple.

The company is yet to commercialize its products as it is yet to receive all the approvals from relevant authorities. Thus company doesn’t have a revenue stream and hence it is inconsequential to take a view on this stock based on its financial statements.

The company’s system will go head to head with Stereoaxis’s system. Hansen’s system seems to have an edge as it can be deployed with any mapping, imaging, and catheter system currently on the market, and will likely be compatible with all future innovations in catheter based therapy. The price point, ease of use and installation are some of the other advantages it enjoys.

The risks that the company is likely to face would be the regulatory risk which is a generic risk faced by the companies in this sector. Its chief competitor Stereoaxis has first mover advantage and would be expected to fight tooth and nail to defend its position.

The company seems to be very richly priced. It has had a dream run since its IPO late last year. It seems that lot of euphoria is built into the price and the risks are not adequately priced. At the end of the day it’s a company which is yet to have a revenue stream and operates in a vertical where cutting edge technology is employed. Thus it may not be the best time to pick the stock.

ahanx8 (36.57) Submitted: 3/12/2007 10:15:49 PM : Start Price: $17.33 HNSN Score: -85.66

Cramer pick

em5 (< 20) Submitted: 2/23/2007 6:48:25 PM : Start Price: $17.87 HNSN Score: -82.21

If you need any more convincing, hop on over to "isrg" and take into account the fact that some of the same guy's who ran that place are running this one.

JasonA25 (65.69) Submitted: 1/25/2007 1:37:32 PM : Start Price: $14.82 HNSN Score: -81.34

With a IPO price of $12 anything under $14 bucks is a buy. Not to mention that the founders are also the same gentlemen that started ISRG.

gr8iml8 (68.82) Submitted: 11/18/2006 12:59:47 PM : Start Price: $13.00 HNSN Score: -80.95

Clearly robotic surgery has a tremendous future, so I think this is a great long term play. Short term, I'm not sure how well HNSN will perform. If true that some of the same folks behind ISRG are behind HNSN, I'm not understanding why the Catheterizaton product would be developed under a separate corporate entity. But at least I won't be late to this party.

--gr8iml8